Emerging companies in synthetic biology and cell therapy are disrupting traditional healthcare solutions, while agricultural biotechnology is delivering disease-free banana varieties and herbicide ...

As for aesthetics, she used fairly feminine, dusky colors tempered with black and white accents ... a small drawer for function contrast the wallpaper and set off the trim on the lampshades ...

White House Press Secretary Karoline Leavitt answered questions about the Trump administration’s decision to suspend federal aid to several assistance programs. Photo: Roberto Schmidt/AFP/Getty ...

The flooring here and throughout much of the house is 6-inch white oak planks ... The mudroom, a half bath with bright wallpaper and a matching pine green vanity, a second half bath, and a ...

A requisite majority of H-class shareholders did not approve the buyout, the companies said. "The proposed privatisation of the Company (Henlius) will not proceed and the listing of the H Shares ...

But local biotech leaders see signs of change in 2025. Amid tough biotech industry market conditions last year, investors and Big Pharma companies were more likely to make deals with later-stage ...

Merck's (NYSE:MRK) recent acquisition of rights to Chinese biotech LaNova Medicines' cancer candidate LM-299 in a deal worth up to $3.3B underscores Big Pharma's appetite for best-in-class assets ...

While 2024 was a “challenging” year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months. On November 28 ...